메뉴 건너뛰기
Medical Journal of Australia
Volumn 169, Issue 2, 1998, Pages 91-92
Venlafaxine withdrawal reactions
Author keywords

[No Author keywords available]
Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE; NORADRENALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;
EID: 0032551566     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb140191.x     Document Type: Short Survey
Times cited : (18)
References (8)
  • 1
    • 0029971789 scopus 로고    scopus 로고
    • Possible venlafaxine withdrawal syndrome
    • Farah A, Lauer TE. Possible venlafaxine withdrawal syndrome [letter]. Am J Psychiatry 1996; 153: 576.
    • (1996) Am J Psychiatry , vol.153 , pp. 576
    • Farah, A.1    Lauer, T.E.2
  • 3
    • 0029852182 scopus 로고    scopus 로고
    • Venlafaxine withdrawal symptoms
    • Benazzi F. Venlafaxine withdrawal symptoms [letter]. Can J Psychiatry 1996; 41: 487
    • (1996) Can J Psychiatry , vol.41 , pp. 487
    • Benazzi, F.1
  • 4
    • 0030845171 scopus 로고    scopus 로고
    • Withdrawal syndrome after discontinuation of venlafaxine
    • Agelink MW, Zitzelsberger A, Klieser E. Withdrawal syndrome after discontinuation of venlafaxine [letter]. Am J Psychiatry 1997; 154: 1473-1474.
    • (1997) Am J Psychiatry , vol.154 , pp. 1473-1474
    • Agelink, M.W.1    Zitzelsberger, A.2    Klieser, E.3
  • 5
    • 0029584197 scopus 로고
    • Potential withdrawal syndrome associated with SSRI discontinuation
    • Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. Ann Pharmacother 1995; 29: 1284-1285.
    • (1995) Ann Pharmacother , vol.29 , pp. 1284-1285
    • Lazowick, A.L.1    Levin, G.M.2
  • 6
    • 0029904001 scopus 로고    scopus 로고
    • A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal
    • Price JS, Waller PC, Wood SM, Mackay AVP. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996; 42: 757-763.
    • (1996) Br J Clin Pharmacol , vol.42 , pp. 757-763
    • Price, J.S.1    Waller, P.C.2    Wood, S.M.3    Mackay, A.V.P.4
  • 7
    • 0003189355 scopus 로고    scopus 로고
    • SSRIs and withdrawal syndrome
    • ADRAC. SSRIs and withdrawal syndrome. Aust Adv Drug React Bull 1996; 15: 3.
    • (1996) Aust Adv Drug React Bull , vol.15 , pp. 3
  • 8
    • 3543019420 scopus 로고    scopus 로고
    • Sydney: MediMedia Australia
    • Caswell A, editor. Efexor. 1997 MIMS Annual. Sydney: MediMedia Australia, 1997: 3-280-3-282.
    • (1997) Efexor. 1997 MIMS Annual , pp. 3280-3282
    • Caswell, A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.